Top compounds associated with response to CTNND2


Feature Type Standardized
Nominal ANOVA
mRNA thapsigargin GDSC1000 pan-cancer AAC -0.064 0.07
mRNA GSK2636771 CTRPv2 pan-cancer AAC -0.078 0.07
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.068 0.07
mRNA AZD4547 CTRPv2 pan-cancer AAC 0.069 0.07
mRNA JQ-1:vorinostat (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.06 0.07
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.063 0.07
mRNA QL-XI-92 GDSC1000 pan-cancer AAC 0.056 0.08
mRNA thapsigargin gCSI pan-cancer AAC -0.1 0.08
mRNA BRD1812 CTRPv2 pan-cancer AAC 0.063 0.08
mRNA SGX-523 CTRPv2 pan-cancer AAC -0.066 0.08
Download CSV